As of April 2026, the FDA announced removal of injectable GHK-Cu from the Category 2 restricted list, with formal implementation expected July 2026
Even those of us who eat right and work out have to fend off chronic disease eventually, in the form of heart disease, cancer, Alzheimers and metabolic disease
However, comprehensive research comparing the effects of GLP-1RA and TZD is limited
Our formulations are designed to ensure that you can enjoy the benefits of glutathione without the unpleasant taste
We also wish to thank Peter Ravn (MedImmune Ltd, Cambridge, UK) for intellectual input into GLP-1 analogue peptide stabilization, Bojana Popovic and Daniel Cannon (MedImmune Ltd, Cambridge, UK) for generating and analysing the peptide homology model, Adrian Podmore (MedImmune Ltd, Cambridge, UK) for conducting the aggregation and stability testing, Richard Kay (LGC, Fordham, UK) for conducting the mass spectrometry metabolites identification work, Marcella Petrone and John Hood (MedImmune Ltd, Cambridge, UK) for performing PK-PD simulations and analysis as well as Christopher Rhodes (MedImmune LLC, Gaithersburg, MD, USA) for his critical review of this manuscript
Dr Wedgeworths recommendation: fake it with self-tan products, the only truly safe way to tan
